Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideTMOThermo Fisher Scientific
FinDog View：Neutral
VEEVVeeva Systems
FinDog View：Neutral
| Metric | TMO | VEEV |
|---|
| Close | 697.00 | 312.96 |
| Market Cap | $258B | $52.3B |
| 1M | +3.25% | +9.64% |
| P/E (TTM) | 36.4 | 50.4 |
| Forward P/E | 24.6 | 33.6 |
| P/E 5-Yr Percentile | 78 | 30 |
| P/S | 5.4 | 14.8 |
| P/B | 4.7 | 6.9 |
| Dividend Yield | 0.29% | — |
| Latest Quarter Revenue | $12.1B | $928M |
| Revenue YoY | +9.1% | +17.6% |
| Gross Margin | — | 75.0% |
| Latest Quarter EPS | 4.64 | 1.66 |
| Avg Post-Earnings Move | ±1.2% | ±9.2% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | 4 / 4 |
| Shareholder Yield | 1.82% | 0.90% |
| 90-Day Net Insider Buying | −$40.3M | −$15.2M |
TMO · Revenue, Last 8 Quarters ($B)
VEEV · Revenue, Last 8 Quarters ($B)
